A Guiding Light for RA: Insights into Clinical Decision Making, Drug Safety & More
JAK Inhibitors: Are All Promises Fulfilled?
Insights into JAK Inhibitor Use
FDA Discussed 2021 Drug Warnings & Approvals at ACR Annual Meeting
Clinical Rheumatology Year in Review 2021
FDA Requires New Boxed Warnings on JAK Inhibitors, Places Restrictions on Use
AbbVie, Lilly Face New Delays in FDA Approval for Expanded Use of Janus Kinase Inhibitors
